Details of the Drug Combination
General Information of Drug Combination (ID: DCQS52K)
Drug Combination Name |
Metaxalone Brincidofovir
|
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indication |
|
|||||||||||||||||
Component Drugs | Metaxalone | Brincidofovir | ||||||||||||||||
Small molecular drug | Small molecular drug | |||||||||||||||||
2D MOL | 2D MOL | |||||||||||||||||
3D MOL | 3D MOL is unavailable | |||||||||||||||||
High-throughput Screening Result | Testing Cell Line: KBM-7 | |||||||||||||||||
Zero Interaction Potency (ZIP) Score: 4.88 | ||||||||||||||||||
Bliss Independence Score: 4.88 | ||||||||||||||||||
Loewe Additivity Score: 5.82 | ||||||||||||||||||
LHighest Single Agent (HSA) Score: 5.82 | ||||||||||||||||||
References